Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuechu Wang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2023
Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathwayXuechu Wang, Jianping Jia
The Lancet Regional Health. Western Pacific|July 17, 2023
Post-COVID cognitive dysfunction: current status and research recommendations for high risk populationMeina Quan, Xuechu Wang, Min Gong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2026
The impact of cholinesterase inhibitors on cognitive trajectories in mild cognitive impairment patients based on amyloid beta statusWenying Liu, Yan Li, Wei Qin, et al.
Alzheimer'S Research & Therapy|May 9, 2024
Cerebrospinal fluid α-synuclein adds the risk of cognitive decline and is associated with tau pathology among non-demented older adultsWenying Liu, Wenwen Li, Zhaojun Liu, et al.
Progress in Neurobiology|October 2, 2023
The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: From pathophysiology to therapeutic approachesWenying Liu, Yan Li, Tan Zhao, et al.
Ageing Research Reviews|August 22, 2021
Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysisHeng Zhang, Yan Wang, Diyang Lyu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Effect of SSRIs on clinical progression in amnestic mild cognitive impairment stratified by Alzheimer's disease pathologyYan Li, Wenying Liu, Xuechu Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2023
Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathwayXuechu Wang, Jianping Jia
The Lancet Regional Health. Western Pacific|July 17, 2023
Post-COVID cognitive dysfunction: current status and research recommendations for high risk populationMeina Quan, Xuechu Wang, Min Gong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2026
The impact of cholinesterase inhibitors on cognitive trajectories in mild cognitive impairment patients based on amyloid beta statusWenying Liu, Yan Li, Wei Qin, et al.
Alzheimer'S Research & Therapy|May 9, 2024
Cerebrospinal fluid α-synuclein adds the risk of cognitive decline and is associated with tau pathology among non-demented older adultsWenying Liu, Wenwen Li, Zhaojun Liu, et al.
Progress in Neurobiology|October 2, 2023
The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: From pathophysiology to therapeutic approachesWenying Liu, Yan Li, Tan Zhao, et al.
Ageing Research Reviews|August 22, 2021
Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysisHeng Zhang, Yan Wang, Diyang Lyu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2025
Effect of SSRIs on clinical progression in amnestic mild cognitive impairment stratified by Alzheimer's disease pathologyYan Li, Wenying Liu, Xuechu Wang, et al.
Pageof 1